The FDA is conducting a safety review based on study data suggesting there may be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel, a skin product used to heal leg and foot ulcers. While the review is ongoing, the FDA recommends health care professionals discuss the potential risks and benefits of using Regranex with their patients.
Posts Tagged ‘Diabetes’
Increased Cancer Risk Associated with Treatment for Diabetic Leg and Foot Ulcers
Written by Sadaka Associates
Friday, 28 March 2008 15:53
No Comments
Friday, 28 March 2008 15:53
No Comments
Doctor Accused of Leak to Drug Maker
Written by Sadaka Associates
Thursday, 31 January 2008 11:33
No Comments
Thursday, 31 January 2008 11:33
No Comments
The New York Times is on fire today with great articles about the pharmaceuticals.
A leading member of the Senate said Wednesday that a prominent diabetes expert had leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company’s diabetes drug Avandia.